Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassandra L Moyer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|August 16, 2023
Targeting nuclear hormone receptors for the prevention of breast cancerCassandra L Moyer, Powel H Brown
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2024
IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 TherapyCassandra L Moyer, Amanda Lanier, Jing Qian, et al.
Cancer Research|December 12, 2019
Rare <i>BRIP1</i> Missense Alleles Confer Risk for Ovarian and Breast CancerCassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, et al.
Breast Cancer Research and Treatment|January 6, 2026
Inhibition of GPX4 induces the death of p53-mutant triple-negative breast cancer cellsWilliam M Tahaney, Amanda Lanier, Jing Qian, et al.
Breast Cancer Research : BCR|February 5, 2024
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growthJing Qian, Yanxia Ma, William M Tahaney, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2025
Targeting the RXR Pathway for the Prevention of Triple Negative Breast CancerCassandra L Moyer, Jamal L Hill, Darian Coleman, et al.
Human Mutation|June 28, 2016
MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch RepairChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|August 16, 2023
Targeting nuclear hormone receptors for the prevention of breast cancerCassandra L Moyer, Powel H Brown
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2024
IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 TherapyCassandra L Moyer, Amanda Lanier, Jing Qian, et al.
Cancer Research|December 12, 2019
Rare <i>BRIP1</i> Missense Alleles Confer Risk for Ovarian and Breast CancerCassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, et al.
Breast Cancer Research and Treatment|January 6, 2026
Inhibition of GPX4 induces the death of p53-mutant triple-negative breast cancer cellsWilliam M Tahaney, Amanda Lanier, Jing Qian, et al.
Breast Cancer Research : BCR|February 5, 2024
The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growthJing Qian, Yanxia Ma, William M Tahaney, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2025
Targeting the RXR Pathway for the Prevention of Triple Negative Breast CancerCassandra L Moyer, Jamal L Hill, Darian Coleman, et al.
Human Mutation|June 28, 2016
MonoSeq Variant Caller Reveals Novel Mononucleotide Run Indel Mutations in Tumors with Defective DNA Mismatch RepairChristopher J Walker, Mario A Miranda, Matthew J O'Hern, et al.
Pageof 1